Balanced news tone
News Sentiment
AFP sentiment intelligence
AFT Pharmaceuticals Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
82/100 classification confidence.
directly relevant articles
high-authority source matches
+4.0% over one week, +2.4% over four weeks, trend active, and near fair-value range.
AFT Pharmaceuticals (ASX:AFP): Why Did This Pharmaceutical Company's Shares Ease Back?
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
AFT Pharmaceuticals (ASX:AFP): Why Did This Pharmaceutical Company's Shares Ease Back?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 02:27
- Source
- Kalkine
AFT Pharmaceuticals (ASX:AFP): Is This Trans-Tasman Drug Developer Gaining the Recognition It Deserves?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 02:45
- Source
- Kalkine
AFT Pharmaceuticals Reports Sustained Sales Growth and Advances in R&D Pipeline
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 06 Jul 2026 21:32
- Source
- Kalkine
AFT Pharmaceuticals Confirms NZD 0.025 Ordinary Dividend with AUD Equivalent and Exchange Rate for July 2026 Payment
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 24 Jun 2026 07:00
- Source
- Kalkine
AFT Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 23 May 2026 07:00
- Source
- simplywall.st
Here's Why We Think AFT Pharmaceuticals (NZSE:AFT) Is Well Worth Watching
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 May 2026 07:00
- Source
- simplywall.st
AFT Pharmaceuticals reports record FY26 profit and growth
- Tone
- Positive 95/100
- Event
- Earnings
- Published
- 20 May 2026 07:00
- Source
- grafa.com
AFT Pharmaceuticals Targets Minimum $300m Revenue After Record Earnings
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 20 May 2026 07:00
- Source
- smallcaps.com.au
AFT Pharmaceuticals appoints new CFO to support global growth
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 18 May 2026 07:00
- Source
- The Globe and Mail
Can Telix Pharmaceuticals (ASX:TLX) Regain Momentum Ahead of Key FDA Decision?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 May 2026 07:00
- Source
- Kalkine
Hikma Pharmaceuticals PLC stock (GB00B128J450): Dividend hike and $250M buyback
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 11 May 2026 07:00
- Source
- ad-hoc-news.de
NZ court dismisses PBL profit appeal against AFT Pharmaceuticals
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 08 Mar 2026 08:00
- Source
- grafa.com
Even though Neuren Pharmaceuticals (ASX:NEU) has lost AU$528m market cap in last 7 days, shareholders are still up 779% over 5 years
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Feb 2026 08:00
- Source
- Market source
Stablepharma and AFT Pharmaceuticals (NZX: AFT; ASX: AFP)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jan 2026 08:00
- Source
- GlobeNewswire
AFT Pharmaceuticals (ASX:AFP): A gem of a dual-listed healthcare company
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 May 2025 07:18
- Source
- Stocks Down Under
AFT Pharmaceuticals (ASX:AFP) at the Pitt Street Research Life Sciences Conference 2024
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Sep 2024 07:00
- Source
- Stocks Down Under